Masaru Fuji

Dr. Masaru Fuji


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
SAShuya Abe
Shuya Abe
Shinichiro TagoShinichiro Tago
Shinichiro Tago
KYKazuaki Yokoyama
Kazuaki Yokoyama
MOMiho Ogawa
Miho Ogawa
TTTomomi Takei
Tomomi Takei
MFMasaru Fuji
Masaru Fuji
Background: To treat diseases caused by genetic variants, it is necessary to identify disease-causing variants in patients. However, since there are a large number of disease-causing variants, the application of AI is required. We propose AI to solve this problem and report the results of its application in identifying disease-causing variants. Methods: To assist physicians in their task of identifying disease-causing variants, we propose an explainable AI (XAI) that combines high estimation accuracy with explainability using a knowledge graph. We integrated databases for genomic medicine and constructed a large knowledge graph that was used to achieve the XAI. Results: We compared our XAI with random forests and decision trees. Conclusion: We propose an XAI that uses knowledge graphs for explanation. The proposed method achieves high estimation performance and explainability. This will support the promotion of genomic medicine.

17 May 2024 in Cancers
Verified
Journal Article
Open access
PDF file
KMKatsuhiko Murakami
Katsuhiko Murakami
Shinichiro TagoShinichiro Tago
Shinichiro Tago
STSho Takishita
Sho Takishita
HMHiroaki Morikawa
Hiroaki Morikawa
RKRikuhiro Kojima
Rikuhiro Kojima
MFMasaru Fuji
Masaru Fuji
When analyzing cancer sample genomes in clinical practice, many structural variants (SVs), other than single nucleotide variants (SNVs), have been identified. To identify driver variants, the leading candidates must be narrowed down. When fusion genes are involved, selection is particularly difficult, and highly accurate predictions from AI is important. Furthermore, we also wanted to determine how the prediction can make more reliable diagnoses. Here, we developed an explainable AI (XAI) suitable for SVs with gene fusions, based on the XAI technology we previously developed for the prediction of SNV pathogenicity. To cope with gene fusion variants, we added new data to the previous knowledge graph for SVs and we improved the algorithm. Its prediction accuracy was as high as that of existing tools. Moreover, our XAI could explain the reasons for these predictions. We used some variant examples to demonstrate that the reasons are plausible in terms of pathogenic basic mechanisms. These results can be seen as a hopeful step toward the future of genomic medicine, where efficient and correct decisions can be made with the support of AI.